Skip to content
Imvax
  • Contact Us
  • Privacy/Terms
  • Join Our Team
Transforming Cancer OutcomesTM
  • About Us
    • Leadership
    • Board of Directors
  • Technology & Proprietary Methodologies
    • Patient Cell Harvest, Treatment, and Implant
    • Immunogenic Cell Death, Patient-Specific Antigens, Innate Immune System Activation
    • Long-term Adaptive Immune Activation and Response
  • Therapeutic Areas
    • Malignant Gliomas
  • Pipeline
    • IGV-001
  • Patients
  • News & Publications
  • Collaboration and Partnerships
Imvax

News & Publications

Imvax > News & Publications
  • Share
    •  
    •  
  • Print

Fierce Biotech names Imvax Inc. as one of its “Fierce 15” Biotech Companies of 2020
September 28, 2020

Imvax Inc. Raises $112 Million in Series C Financing
July 16, 2020

An open letter to the Philadelphia region and the biopharmaceutical community.
June 16, 2020

Imvax Appoints Iphigenia Leonidou Koumenis as Head of Clinical Operations
June 1, 2020

9 Philly Companies on the Cutting Edge of Cell and Gene Therapy Innovation
May 9, 2020

Imvax Appoints Chief Scientific Officer
April 23, 2020

Why is Imvax putting its new brain-cancer vaccine lab in Philly’s old historic district?
September 12, 2019

Former Spark COO Furey to helm cancer vaccines biotech Imvax
September 12, 2019

Philadelphia Immuno-oncology company Imvax hires CEO
September 10, 2019

News

Stay informed about our latest
news and developments.

LEARN MORE

Patients

Our patients are the heart of our company, and they, along with their families, friends and caregivers, are just as much members of the Imvax Team.

LEARN MORE

601 Walnut St, Suite 440 W
Philadelphia, PA 19106

tel 267-900-4110

  • About Us
  • Leadership
  • Board of Directors
  • Technology & Proprietary Methodologies
  • Patient Cell Harvest, Treatment, and Implant
  • Immunogenic Cell Death, Patient-Specific Antigens, Innate Immune System Activation
  • Long-term Adaptive Immune Activation and Response
  • Pipeline
  • IGV-001
  • Therapeutic Areas
  • Malignant Gliomas
close ×
IGV-001
  • Patients
  • News & Publications
  • Collaboration and Partnerships
  • Join Our Team
Website by Axxiem
© Copyright Imvax, Inc. All Right Reserved
Privacy/Terms | Sitemap
By accessing our website or software provided by our third-party vendors, you consent to accept cookies, (including other identifiers). These include pieces of text that are stored on your computer or device. This site uses cookies and Google Analytics to improve navigation, minimize the need to reenter information previously entered on forms, personalize messages, and collect statistical information to improve site navigation and provide content of greatest interest to users.Ok